All filters
Slidesets
Pharmacokinetics and Safety of Pazopanib in Frail Elderly Patients - Félicien Le Louedec
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Effects of Dietary Restriction in Cancer Patients Receiving Irinotecan - Ruben van Eerden
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Dose Individualization Potential for Oral Targeted Oncolytics - Neeltje Steeghs, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Dose Individualization Potential for Checkpoint Inhibitors - Stijn Koolen, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib - Koen Hussaart
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Correlation Between Sunitinib Exposure and Toxicity in a Real-life Patient Cohort - Kim Westerdijk
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Drug - Food Interaction an Unrealized Potential - Nielka van Erp, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Stopping Nucleos(t)ide Analogues: Clinical outcomes of HBs Loss, retreatment and flares- Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Immunological response after stopping Nucs- Andre Boonstra
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Virological biomarkers in patients stopping Nucs- Florian van Bommel, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Review of the FDA/EMA HBV Endpoints Meeting- Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Are ALT Flares Associated with Improved Virological Clearance- Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
High Resolution of Exhausted T cells Ex Vivo in Chronic HBV Infection- Robert Thimme
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Restoration of B cell Antibody Production in Chronic HBV patients- Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Are HBcrAg, HBV RNA and anti-HBc Viable Biomarkers- Florian van Bommel, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Using FNAB to Investigate Intrahepatic Immunology- Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Elimination of Residual HBV Replication and Prevention of cccDNA Generation with the Combination of NrtI and Core Inhibitor- Richard Colonno
Presented at:
International Workshop on HBV Cure 2019
Slidesets
sIRNA based therapy for Chronic Hepatitis B Treatment- Michael Biermer
Presented at:
International Workshop on HBV Cure 2019
Slidesets
NAP's latest update in HBV and HDV- Andrew Vaillant
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Study Design with New Combinations- Marion Peters, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Hypothesized Synergies in new cobmination treatment beyond nucs- Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2019
Slidesets
An Overview of HIV & STI Prevention - Rachael Jones
Presented at:
Nurses & Pharmacists HIV Clinical Forum 2019